Skip to content

Call for patient input on ruxolitinib (Opzelura®) for atopic dermatitis

If you live with atopic dermatitis or care for someone with atopic dermatitis, please send us your input by April 2, 2026. Your input will be anonymous. All questions require an answer. Write N/A if it does not apply to you.
1.Are you a patient living with atopic dermatitis or a caregiver to someone living with atopic dermatitis?(Required.)